Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
CC transcript
Appointed director
Quarterly results

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Vakiener Victoria (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 1,550 shares @ $26.33, valued at $40.8k
09/28/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 8-K Quarterly results
Docs: "Arrowhead Pharmaceuticals Reports Fiscal 2023 Second Quarter Results -Conference Call and Webcast Today, August 7, 2023 at 4:30 p.m. ET"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/06/2023 4 Oliver Tracie (Chief Commercial Officer) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 8,925 shares @ $35.31, valued at $315.1k
07/05/2023 4 Hamilton James C (Chief Discovery/Trans Medicine) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 3,000 shares @ $35.53, valued at $106.6k
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/30/2023 144 Form 144 - Report of proposed sale of securities:
06/29/2023 4 Myszkowski Kenneth Allen (CFO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $36.2, valued at $543k
06/09/2023 SC 13G/A VANGUARD GROUP INC reports a 10.1% stake in Arrowhead Pharmaceuticals Inc.
05/08/2023 4 GIVEN DOUGLAS B (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 6,500 shares @ $40.9, valued at $265.9k
05/05/2023 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 54,928 shares @ $39.14, valued at $2.1M
Sold 24,008 shares @ $38.97, valued at $935.6k
Sold 25,992 shares @ $40.02, valued at $1M
Exercised 54,928 options to buy @ $2.01, valued at $110.4k
Exercised 50,000 options to buy @ $2.01, valued at $100.5k
05/05/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 8-K Quarterly results
03/23/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/20/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/06/2023 4 OLUKOTUN ADEOYE Y (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 11,350 shares @ $32.65, valued at $370.6k
03/01/2023 4 GIVEN DOUGLAS B (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 875 shares @ $32.62, valued at $28.5k
02/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.7% stake in Arrowhead Pharmaceuticals Inc.
02/08/2023 SC 13G/A STATE STREET CORP reports a 5.6% stake in AMENDED FILING ARROWHEAD PHARMACEUTICALS INC
02/06/2023 8-K Quarterly results
02/06/2023 10-Q Quarterly Report for the period ended December 31, 2022
01/30/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "3.1 1 SECOND AMENDED AND RESTATED BYLAWS OF ARROWHEAD PHARMACEUTICALS, INC. ARTICLE I STOCKHOLDERS"
01/30/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
01/26/2023 SC 13G/A BlackRock Inc. reports a 12% stake in ARROWHEAD PHARMACEUTICALS INC
01/20/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
01/20/2023 SC 13G BlackRock Inc. reports a 12% stake in ARROWHEAD PHARMACEUTICALS INC
01/12/2023 4 Ferrari Mauro (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 De Backer Marianne (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 Vakiener Victoria (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Disposed/sold 1,764 shares @ $0
Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 PERRY MICHAEL S (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
01/11/2023 4 GIVEN DOUGLAS B (Director) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 7,867 shares @ $0
Granted 4,593 options to buy @ $33.03, valued at $151.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy